| Dr Diane K Robbins, PHD | |
|
16168 Beach Blvd, Ste 265, Huntington Beach, CA 92647-3886 | |
| (714) 843-0663 | |
| Not Available |
| Full Name | Dr Diane K Robbins |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 16168 Beach Blvd, Huntington Beach, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184628422 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PSY14815 (California) | Primary |
| 106H00000X | Marriage & Family Therapist | MFC19668 (California) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Diane K Robbins, PHD 16168 Beach Blvd, Ste 265, Huntington Beach, CA 92647-3886 Ph: (714) 843-0663 | Dr Diane K Robbins, PHD 16168 Beach Blvd, Ste 265, Huntington Beach, CA 92647-3886 Ph: (714) 843-0663 |
News Archive
Scientists have discovered a protein secreted by tuberculosis bacteria that could be a promising new vaccine candidate, they report today in Proceedings of the National Academy of Sciences. The protein could also be used to improve diagnosis of TB.
A prominent protein activated by inflammation is the key instigator that converts glioblastoma multiforme cells to their most aggressive, untreatable form and promotes resistance to radiation therapy, an international team lead by researchers at The University of Texas MD Anderson Cancer Center reported online today in the journal Cancer Cell.
New University of Liverpool research, presented at an international conference, confirms that a novel approach to the treatment of chronic myeloid leukemia (CML) can safely increase treatment success and reduce negative side effects.
A major international study has uncovered three molecules that have the potential to be developed into new drugs to treat epilepsy.
Idera Pharmaceuticals, Inc. today announced preliminary results from a Phase 1 clinical trial of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for potential applications in autoimmune and inflammatory diseases. In this trial, healthy subjects in five dosage cohorts received single doses of IMO-3100 from 0.04 to 0.64 mg/kg. IMO-3100 was well tolerated at all dose levels.
› Verified 7 days ago
Dr. Janet Lynn Sonne, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 21378 Estepa Cir, Huntington Beach, CA 92648 Phone: 714-969-9377 Fax: 714-969-6445 | |
Dr. Pamela I Berg, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 16152 Beach Blvd, Suite 200, Huntington Beach, CA 92647 Phone: 714-841-6772 Fax: 714-841-6775 | |
Dr. Jerry George Soucy, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 16152 Beach Blvd, Huntington Beach, CA 92647 Phone: 714-842-7060 Fax: 714-965-6220 | |
Ms. Kathryn Tinsley, LEP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7755 Center Ave, Suite 1100, Huntington Beach, CA 92647 Phone: 714-270-9004 | |
Dr. Sylva Frock, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 600 Main St., 250, Huntington Beach, CA 92648 Phone: 214-729-9797 | |
Dr. Marie Antoinette Mulherin, ED.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7755 Center Ave, Suite 1100, Huntington Beach, CA 92647 Phone: 714-892-1985 Fax: 714-372-2239 | |
Dr. Erin Bray, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 22001 Newport Cir, Huntington Beach, CA 92646 Phone: 949-646-8385 |